KLSE (MYR): CAROTEC (0076)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.02
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Market Cap
0 Million
NOSH
911 Million
Latest Quarter
31-Dec-2011 [#2]
Announcement Date
20-Feb-2012
Next Quarter
31-Mar-2012
Est. Ann. Date
01-Jun-2012
Est. Ann. Due Date
30-May-2012
QoQ | YoY
50.63% | 23.05%
Revenue | NP to SH
50,164.000 | -40,315.000
RPS | P/RPS
5.51 Cent | 0.00
EPS | P/E | EY
-4.43 Cent | 0.00 | 0.00%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.01 | 0.00
QoQ | YoY
5.62% | 60.4%
NP Margin | ROE
-80.37% | -885.27%
F.Y. | Ann. Date
31-Dec-2011 | 20-Feb-2012
Latest Audited Result
30-Jun-2011
Announcement Date
10-Nov-2011
Next Audited Result
30-Jun-2012
Est. Ann. Date
10-Nov-2012
Est. Ann. Due Date
27-Dec-2012
Revenue | NP to SH
40,010.000 | -23,695.000
RPS | P/RPS
4.39 Cent | 0.00
EPS | P/E | EY
-2.60 Cent | 0.00 | 0.00%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.02 | 0.00
YoY
74.38%
NP Margin | ROE
-59.22% | -113.04%
F.Y. | Ann. Date
30-Jun-2011 | 29-Aug-2011
Revenue | NP to SH
61,948.000 | -48,496.000
RPS | P/RPS
6.80 Cent | 0.00
EPS | P/E | EY
-5.32 Cent | 0.00 | 0.00%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
25.31% | -217.92%
NP Margin | ROE
-78.29% | -1,064.00%
F.Y. | Ann. Date
31-Dec-2011 | 20-Feb-2012
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 3 / 4 | 75.00% | 3 / 8 | 37.50% |
Total Positive Profit Years | 0 / 4 | 0.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | -94.88% | -60.54% | ||
Average Net Profit Margin | -86.74% | -75.30% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 2 / 5 | 40.00% | 4 / 8 | 50.00% |
Continuous Quarters Of Positive Profit | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
Total Dividend Years | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 8 | 0.00% |
Average ROE | -73.01% | -41.83% | ||
Average Net Profit Margin | -16.89% | -6.33% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 50,164 | 61,948 | 40,010 | 91,733 | 123,983 |
NP to SH | -40,315 | -48,496 | -23,695 | -11,177 | -21,785 |
Dividend | 0 | 0 | 0 | 427 | 683 |
Adjusted EPS | -4.43 | -5.32 | -2.60 | -1.23 | -2.39 |
Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.05 | 0.08 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 38.48% | 72.93% | 48.77% | 43.42% | -28.06% |
NP to Owner | 50.63% | 23.05% | -217.92% | 20.48% | 54.88% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 50.63% | 23.05% | -217.92% | 20.48% | 54.88% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 25.38% | -59.54% | -45.32% | 54.83% | -50.04% | -32.47% | -83.54% | -67.73% | -56.38% |
NP to Owner | -70.14% | -85.06% | -260.69% | -104.67% | -122.61% | -333.88% | 74.38% | -8.77% | -111.99% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -70.28% | -85.21% | -260.99% | -104.67% | -122.61% | -333.88% | 74.38% | -8.77% | -111.99% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
recently there was an article interviewing the MD and he was saying that they hv a lot of interested buyers in their business a world producer in bio fuel.hovid too affected bcos shareholders given carotech shares as dividend
2012-03-30 11:21
From my past experience they will always give good views before the due, and might unload theirs,My experience: MEMS, MTONE, PAXELNT, KIMBLE
2012-03-30 11:48
most recent maxbiz.my advise of another potential delisting is IE-screwed up ctr shud hv been delisted long ago
2012-03-30 11:50
One doctor shared with me that they produce very goo Vitamin E. Dont't know why the stock is suffering losses
2012-03-30 21:31
Carotec owe people alot of money la. Their research failed.
Bro Raymond - the Vitamin E stuff I agreed with you. But the research
project using Oil Palm is burning MR HO. and now....
Carotec owes TAIKO @ BATU KAWAN - so now look at KLK and Batu Kawan shares.....their shares BERPULUH-PULUH RINGGIT LO.
2012-03-30 21:59
Bear in mind the counter is on the way for @de-listing@ which is beyond their control , you either can run now or drop your pant & run like headless chicken in coming days , ha ha
2012-04-01 10:01
Carotec is in the process of being wound up. I am wondering what the highly anticipated FDA trials would mean since the patent belongs to Carotech?
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=carotech&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT
2015-04-14 14:55
tcgien
this counter can play contra, intraday , but at 0.04, sell 0.045. make 10% profit :p
2012-03-06 18:42